Challenges biosimilar manufacturers may face in encouraging switching

Chain Drug Review is a publication that reports on the retail drug industry. With 21 issues per year, it provides news and information on drug chains and new products, and features expert opinions. The publication delivers timely and informative perspectives on the events and trends impacting the chain drug retailing industry.

Chain Drug Review reports interesting news and helpful information about the chain drug industry. Their latest e-magazine, available to registered users, features an article written by our own George I’Ons, the Head of Product Strategy here at Owen Mumford Pharmaceutical Services. He discusses the challenges biosimilar manufacturers may face in encouraging switching especially with respect to the drug delivery device.